Joao Siffert M.D., SVP, R&D at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 5,970 shares at $2.63 ($16K) on 2013-12-18, disclosed to the SEC on 2013-12-20.
Scheduled sale ($16k) by SVP, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVNR | SELL | 2014-10-24 | $99K | — | Filing → |
| AVNR | SELL | 2014-05-30 | $70K | — | Filing → |
| AVNR | SELL | 2013-09-19 | $89K | — | Filing → |